Hemabate

Active Ingredient(s): Carboprost Tromethamine
FDA Approved: * January 9, 1979
Pharm Company: * PHARMACIA AND UPJOHN
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Hemabate Overview

Carboprost (INN, trade names for the tromethamine salts Hemabate, Tham) is a synthetic prostaglandin analogue of PGF2α (specifically, it is 15-methyl-PGF2α) with oxytocic properties. Carboprost main use is in the obstetrical emergency of postpartum hemorrhage which reduces postpartum bleeding during these circumstances. Contents 1 Indication 2 Contraindication 3 Precautions 4 Adverse Effects 5 Storage and Availability 6 Synthesis 7 See also 8 References 9 External links In...

Read more Hemabate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carboprost

Recent Hemabate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Hemabate: (1 result)

Sorted by National Drug Code

• 0009-0856 Hemabate 250 ug/ml Intramuscular Injection, Solution by Pharmacia and Upjohn Company

Other drugs which contain Carboprost Tromethamine or a similar ingredient: (1 result)

• CARBOPROST TROMETHAMINE